148 related articles for article (PubMed ID: 36371450)
1. Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5.
Mangou K; Moore AJ; Thiam LG; Ba A; Orfanó A; Desamours I; Ndegwa DN; Goodwin J; Guo Y; Sheng Z; Patel SD; Diallo F; Sene SD; Pouye MN; Faye AT; Thiam A; Nunez V; Diagne CT; Sadio BD; Shapiro L; Faye O; Mbengue A; Bei AK
Sci Rep; 2022 Nov; 12(1):19403. PubMed ID: 36371450
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.
Ajibaye O; Osuntoki AA; Balogun EO; Olukosi YA; Iwalokun BA; Oyebola KM; Hikosaka K; Watanabe YI; Ebiloma GU; Kita K; Amambua-Ngwa A
Malar J; 2020 Jan; 19(1):6. PubMed ID: 31906953
[TBL] [Abstract][Full Text] [Related]
3. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.
Bustamante LY; Bartholdson SJ; Crosnier C; Campos MG; Wanaguru M; Nguon C; Kwiatkowski DP; Wright GJ; Rayner JC
Vaccine; 2013 Jan; 31(2):373-9. PubMed ID: 23146673
[TBL] [Abstract][Full Text] [Related]
4. High genetic and haplotype diversity in vaccine candidate
Oboh MA; Asmorom N; Falade C; Ojurongbe O; Thomas BN
PeerJ; 2023; 11():e16519. PubMed ID: 38099304
[TBL] [Abstract][Full Text] [Related]
5. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces
Bjerkan L; Visweswaran GRR; Gudjonsson A; Labbé GM; Quinkert D; Pattinson DJ; Spång HCL; Draper SJ; Bogen B; Braathen R
Front Immunol; 2021; 12():720550. PubMed ID: 34733274
[TBL] [Abstract][Full Text] [Related]
6. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate
Ouattara A; Tran TM; Doumbo S; Adams M; Agrawal S; Niangaly A; Nelson-Owens S; Doumtabé D; Tolo Y; Ongoiba A; Takala-Harrison S; Traoré B; Silva JC; Crompton PD; Doumbo OK; Plowe CV
Am J Trop Med Hyg; 2018 Jul; 99(1):43-50. PubMed ID: 29848401
[TBL] [Abstract][Full Text] [Related]
7. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
[TBL] [Abstract][Full Text] [Related]
8. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.
Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA
Malar J; 2014 Aug; 13():326. PubMed ID: 25135070
[TBL] [Abstract][Full Text] [Related]
9. Analysis of genetic diversity and population structure of gene encoding cell-traversal protein for ookinetes and sporozoites (CelTOS) vaccine candidate antigen in global Plasmodium falciparum populations.
Pirahmadi S; Zakeri S; Mehrizi AA; Djadid ND
Infect Genet Evol; 2018 Apr; 59():113-125. PubMed ID: 29391203
[TBL] [Abstract][Full Text] [Related]
10. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.
Tran TM; Ongoiba A; Coursen J; Crosnier C; Diouf A; Huang CY; Li S; Doumbo S; Doumtabe D; Kone Y; Bathily A; Dia S; Niangaly M; Dara C; Sangala J; Miller LH; Doumbo OK; Kayentao K; Long CA; Miura K; Wright GJ; Traore B; Crompton PD
J Infect Dis; 2014 Mar; 209(5):789-98. PubMed ID: 24133188
[TBL] [Abstract][Full Text] [Related]
11. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.
Williams AR; Douglas AD; Miura K; Illingworth JJ; Choudhary P; Murungi LM; Furze JM; Diouf A; Miotto O; Crosnier C; Wright GJ; Kwiatkowski DP; Fairhurst RM; Long CA; Draper SJ
PLoS Pathog; 2012; 8(11):e1002991. PubMed ID: 23144611
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria.
Partey FD; Castberg FC; Sarbah EW; Silk SE; Awandare GA; Draper SJ; Opoku N; Kweku M; Ofori MF; Hviid L; Barfod L
PLoS One; 2018; 13(6):e0198371. PubMed ID: 29883485
[TBL] [Abstract][Full Text] [Related]
13. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
[TBL] [Abstract][Full Text] [Related]
14. A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys.
Douglas AD; Baldeviano GC; Lucas CM; Lugo-Roman LA; Crosnier C; Bartholdson SJ; Diouf A; Miura K; Lambert LE; Ventocilla JA; Leiva KP; Milne KH; Illingworth JJ; Spencer AJ; Hjerrild KA; Alanine DG; Turner AV; Moorhead JT; Edgel KA; Wu Y; Long CA; Wright GJ; Lescano AG; Draper SJ
Cell Host Microbe; 2015 Jan; 17(1):130-9. PubMed ID: 25590760
[TBL] [Abstract][Full Text] [Related]
15. Limited genetic variations of the Rh5-CyRPA-Ripr invasion complex in
Waweru H; Kanoi BN; Kuja JO; Maranga M; Kongere J; Maina M; Kinyua J; Gitaka J
Front Trop Dis; 2023 Mar; 4():1102265. PubMed ID: 38406638
[TBL] [Abstract][Full Text] [Related]
16. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.
Weaver R; Reiling L; Feng G; Drew DR; Mueller I; Siba PM; Tsuboi T; Richards JS; Fowkes FJI; Beeson JG
Sci Rep; 2016 Sep; 6():33094. PubMed ID: 27604417
[TBL] [Abstract][Full Text] [Related]
17. PfRH5 as a candidate vaccine for Plasmodium falciparum malaria.
Drew DR; Beeson JG
Trends Parasitol; 2015 Mar; 31(3):87-8. PubMed ID: 25704640
[TBL] [Abstract][Full Text] [Related]
18. A complex equation - adding to Plasmodium falciparum invasion.
Björnsson KH; Barfod L
Trends Parasitol; 2023 Mar; 39(3):160-162. PubMed ID: 36682939
[TBL] [Abstract][Full Text] [Related]
19. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
Douglas AD; Williams AR; Illingworth JJ; Kamuyu G; Biswas S; Goodman AL; Wyllie DH; Crosnier C; Miura K; Wright GJ; Long CA; Osier FH; Marsh K; Turner AV; Hill AV; Draper SJ
Nat Commun; 2011 Dec; 2():601. PubMed ID: 22186897
[TBL] [Abstract][Full Text] [Related]
20. Assessing the functional impact of PfRh5 genetic diversity on ex vivo erythrocyte invasion inhibition.
Moore AJ; Mangou K; Diallo F; Sene SD; Pouye MN; Sadio BD; Faye O; Mbengue A; Bei AK
Sci Rep; 2021 Jan; 11(1):2225. PubMed ID: 33500482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
